Lumanity Executive and Leadership Team

Julie Munakata, the Global President, HEOR at Lumanity, directs the strategic generation of health economics and outcomes research to demonstrate product value. Munakata oversees the integration of real-world evidence into payer submissions, ensuring that pharmaceutical innovations reach patients at appropriate price points. By managing cross-functional teams across North America and Europe, the Global President, HEOR aligns scientific data with regulatory requirements to support sustainable market access. Julie Munakata drives the development of robust evidence frameworks that empower providers and regulators to make informed decisions. This leadership role involves constant collaboration with commercial teams to translate complex clinical findings into compelling value propositions. Through the application of rigorous analytical methodologies, the Global President, HEOR optimizes the commercialization trajectory for diverse biotech portfolios, ultimately securing long-term product viability in highly competitive global healthcare markets.

Christopher Evans, the President Patient-Centered Outcomes at Lumanity, architects strategies that prioritize the patient experience within clinical and commercial development. Evans leads initiatives to capture patient-reported outcomes, ensuring that medical advances reflect the actual needs of those receiving treatment. By overseeing global research operations, the President Patient-Centered Outcomes transforms qualitative patient data into actionable insights for pharmaceutical partners. Christopher Evans drives the alignment of these insights with regulatory and payer expectations to facilitate smoother product launches. This role requires deep engagement with stakeholders to ensure that product narratives remain relevant and impactful across diverse international markets. By focusing on the human element of medical innovation, the President Patient-Centered Outcomes enhances the overall value proposition of new therapies. Through consistent application of patient-centric methodologies, Evans ensures that Lumanity remains at the forefront of evidence-based healthcare delivery.

Stephen Weisman, the Global President at Lumanity, directs the overarching operational strategy and international expansion efforts. Weisman manages the integration of medical, commercial, and regulatory affairs to ensure cohesive service delivery across all global offices. By overseeing the firm's presence in over 50 countries, the Global President maintains high standards of excellence in evidence generation and commercialization support. Stephen Weisman drives the alignment of internal resources with the evolving needs of top-tier pharmaceutical and biotech clients. This leadership role involves frequent interaction with the Board to refine long-term growth objectives and market positioning. Through the optimization of cross-regional workflows, the Global President ensures that Lumanity delivers consistent, high-impact results for patients and providers alike. Weisman fosters a culture of decisive action, enabling the organization to navigate complex healthcare landscapes while maintaining a focus on sustainable commercial success.

Robert Budreau, the President & Producer at Lumanity, directs the creative and logistical execution of high-stakes product campaigns and commercial launches. Budreau oversees the transformation of complex scientific data into compelling, narrative-driven content that resonates with global stakeholders. By managing the production lifecycle of brand assets, the President & Producer ensures that every campaign aligns with the broader commercial strategy of the client. Robert Budreau drives the integration of visual and written communication to simplify intricate medical information for diverse audiences, including payers and regulators. This leadership role involves coordinating with internal creative teams to maintain brand consistency across all regional markets. Through the application of innovative storytelling techniques, the President & Producer enhances the market impact of new medical products. Budreau ensures that all promotional and educational materials support the ultimate goal of accelerating patient access to life-changing therapies.

Marissa Poli, the President at Lumanity, directs internal scaling initiatives and operational efficiency programs to support the firm's rapid growth. Poli oversees the alignment of departmental functions, ensuring that medical and commercial teams operate with maximum synergy. By managing the infrastructure required for large-scale evidence generation, the President facilitates the delivery of transformative outcomes for pharmaceutical partners. Marissa Poli drives the implementation of standardized processes that allow for consistent service quality across North America and Asia. This leadership role involves close collaboration with other C-suite executives to refine the company's service model and respond to shifting market demands. Through the optimization of internal resources, the President ensures that Lumanity maintains its competitive edge in the healthcare consulting sector. Poli focuses on building resilient systems that empower experts to translate complex data into real-world insights, ultimately driving sustainable success for clients.

John Howley, the President, Communications (US) at Lumanity, directs all strategic messaging and stakeholder engagement efforts within the North American market. Howley oversees the development of communication frameworks that translate complex scientific data into clear, actionable narratives for providers and payers. By managing the US-based communications team, the President, Communications (US) ensures that product launches are supported by robust, evidence-based messaging. John Howley drives the alignment of public relations and medical communications to maximize the impact of new therapies in the marketplace. This leadership role involves constant coordination with commercial and regulatory teams to ensure that all external communications remain compliant and persuasive. Through the application of targeted communication strategies, the President, Communications (US) enhances the visibility and value of client products. Howley ensures that Lumanity effectively communicates the clinical and economic benefits of medical advances to key decision-makers.